Does Cilostazol Prevent Recurrent Stroke in Women? Does Cilostazol Prevent Recurrent Stroke in Women?
Although dual antiplatelet therapy using cilostazol is associated with a lower risk of recurrent stroke in men, it has no significant benefit for women, a sub-analysis of CSPS.com results suggests.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 22, 2022 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
Hint of Benefit From Cilostazol in Preventing Carotid Restenosis Hint of Benefit From Cilostazol in Preventing Carotid Restenosis
Medscape Medical News (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - February 25, 2020 Category: Radiology Tags: Neurology & Neurosurgery News Source Type: news
Leg pain medication may prevent re-blockage of neck arteries after a stent
(American Heart Association) Adding cilostazol, an antiplatelet medication for leg pain, to other drugs tended to prevent re-blockage of carotid artery stents within two years.This is the first trial to show potential effectiveness of medical management for prevention of in-stent restenosis after carotid artery stenting. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 21, 2020 Category: International Medicine & Public Health Source Type: news
Heart Meds May Prevent Vascular Dementia After Stroke Heart Meds May Prevent Vascular Dementia After Stroke
Cilostazol and isosorbide mononitrate have neuroprotective potential after lacunar stroke, which carries a high risk for vascular dementia and cognitive decline.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - May 6, 2019 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
Drugs to prevent stroke and dementia show promise in early trial
Treatments that prevent recurrence of types of stroke and dementia caused by damage to small blood vessels in the brain have moved a step closer, following a small study. The drugs - called cilostazol and isosorbide mononitrate - are already used to treat other conditions, such as heart disease and angina. This is the first time they have been tested in the UK for the treatment of stroke or vascular dementia. (Source: World Pharma News)
Source: World Pharma News - April 29, 2019 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
cilostazol (Pletal)
Title: cilostazol (Pletal)Category: MedicationsCreated: 4/17/1999 12:00:00 AMLast Editorial Review: 3/19/2019 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - March 19, 2019 Category: Cardiology Source Type: news
Dual Antiplatelet Therapy With Cilostazol Cuts Recurrent Stroke Dual Antiplatelet Therapy With Cilostazol Cuts Recurrent Stroke
New results show cilostazol plus aspirin or clopidogrel reduced recurrent stroke rate by half over aspirin or clopidogrel alone in high-risk stroke patients without increased bleeding.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 7, 2019 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news
Blood Thinning Drug May Be Safer Option Against Recurrent Stroke
THURSDAY, Feb. 7, 2019 -- Taking the blood thinner Pletal (cilostazol) with either aspirin or clopidogrel (best known as Plavix) lowers stroke patients ' risk of a subsequent stroke better than taking aspirin or clopidogrel alone, a new study... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 7, 2019 Category: General Medicine Source Type: news
Cilostazol Works in DAPT for Secondary Stroke Prevention
(MedPage Today) -- ' Fantastic result ' with phosphodiesterase-3 inhibitor (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - February 7, 2019 Category: Primary Care Source Type: news
Cilostazol-combo antiplatelet therapy reduced risk for recurrent stroke
(American Heart Association) The long-term combination of cilostazol with aspirin or clopidogrel resulted in fewer recurrent strokes than with aspirin or clopidogrel alone in high-risk patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 6, 2019 Category: International Medicine & Public Health Source Type: news
Quality of care for peripheral artery disease is low
This study is a “call to action” to identify and implement effective physician-targeted and patient-targeted strategies aimed at improving quality of care. These strategies should take advantage of recent advances in behavior change, including leveraging an individual’s social support network to help them mak e lifestyle changes, and providing physicians with feedback about the quality of care they provide to patients with peripheral artery disease.AUTHORSJoseph Ladapo of UCLA and Jeffrey Berger of New York University.JOURNALThe studyis published online by the Journal of the American College of Cardiology.FUNDINGThe...
Source: UCLA Newsroom: Health Sciences - May 1, 2017 Category: Universities & Medical Training Source Type: news
Cilostazol: An Option for Ischemic Stroke After ICH? Cilostazol: An Option for Ischemic Stroke After ICH?
The antiplatelet agent cilostazol showed promising results among this difficult-to-treat group in the PICASSO trial.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 2, 2017 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
Cilostazol Fails to Best Aspirin for Post-Stroke Secondary Prevention (CME/CE)
(MedPage Today) -- Non-inferior overall but MI rates higher with PDE3 inhibitor (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - February 25, 2017 Category: Geriatrics Source Type: news
Pletal (Cilostazol) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - September 26, 2016 Category: Drugs & Pharmacology Source Type: news
Cilostazol Bridges Surgical DES Patients Without DAPTCilostazol Bridges Surgical DES Patients Without DAPT
Based on long-term follow-up in an observational study, the PDE-3 inhibitor was called an "ingenious bridge" for patients taken off standard dual-antiplatelet therapy during surgery. Heartwire from Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - May 11, 2015 Category: Cardiology Tags: Cardiology News Source Type: news
